User:Justin Reggi/sandbox

Flexion Therapeutics, Inc. is a Woburn, MA - based company that is developing long-lasting, joint-injection (intra-articular injection) therapies for the treatment of osteoarthritis. Flexion’s pipeline consists of three novel drug candidates (FX005, FX006, FX007) for the treatment of pain associated with mild, moderate, and severe osteoarthritis. FX005 is a sustained release, intra-articular p38 Mitogen Activated Protein Kinase (p38 MAP) inhibitor, FX006 is a sustained release, intra-articular steroid, and FX007 is a sustained release, intra-articular TrkA receptor antagonist.